Evolution and Impact of the National Tuberculosis Control Programme

Tuberculosis (TB) has been one of India’s most persistent public health challenges for decades. When the National Tuberculosis Control Programme (NTCP) was launched in 1962, it marked the beginning of a structured national effort to tackle this deadly disease. Over the years, this programme has undergone significant transformations-from the original NTP to the Revised National Tuberculosis Control Programme (RNTCP), and now the National Tuberculosis Elimination Programme (NTEP)-reflecting India’s evolving strategies and growing commitment to eliminating TB entirely.

The birth of India’s tuberculosis control efforts 🔗

India’s systematic approach to TB control began when the Government of India launched the National TB Programme in 1962. This initiative followed the District TB Centre model, focusing primarily on BCG vaccination and providing treatment through centralized facilities at the district level. The programme relied heavily on X-ray-based diagnosis and used Streptomycin and Isoniazid (INH) as the primary treatment drugs.

While the NTP represented a significant step forward, it operated under considerable constraints. The Indian government at the time lacked sufficient financial resources to meet its public health goals, leading to dependence on external funding from organizations like the World Health Organization (WHO) and the Swedish International Development Agency (SIDA). In 1978, BCG vaccination responsibilities were shifted to the Expanded Programme on Immunisation, allowing the TB programme to focus more specifically on case detection and treatment.

Identifying shortcomings: the 1992 review 🔗

A critical turning point came in 1992 when a joint review by the Government of India, WHO, and SIDA evaluated the NTCP’s performance. The findings revealed several significant weaknesses: inadequate budgetary allocations, drug shortages, over-reliance on X-ray for diagnosis, insufficient utilization of sputum microscopy facilities, an emphasis on case detection rather than ensuring cure, and inconsistent treatment regimens across regions.

This same year, the WHO declared TB a global emergency, which added urgency to reform efforts. The review made clear that simply detecting cases was not enough-the focus needed to shift toward achieving high cure rates through standardized, supervised treatment protocols.

The revised approach: DOTS strategy implementation 🔗

In response to these challenges, the Government of India adopted the Directly Observed Treatment Short-course (DOTS) strategy recommended by WHO. This approach was launched under the Revised National Tuberculosis Control Programme (RNTCP) in 1997, after a pilot phase from 1993 to 1996.

The DOTS strategy introduced five essential components for effective TB control:

Political and administrative commitment: This ensured government support at all levels with prioritized monitoring, recording, and training systems.

Quality diagnosis through sputum microscopy: The programme shifted from expensive X-ray diagnosis to more accessible and accurate sputum smear microscopy as the primary diagnostic method.

Uninterrupted drug supply: Ensuring quality-assured anti-TB drugs were available at all healthcare levels became a priority.

Directly observed treatment: A healthcare worker or trained community member would watch patients swallow their medications, particularly during the crucial initial treatment phase.

Systematic monitoring and accountability: Standardized recording and reporting systems tracked treatment outcomes rigorously.

The RNTCP set ambitious targets: 70% case detection rate and 85% cure rate among newly detected sputum smear-positive cases. By 2006, the programme achieved nationwide coverage, and by 2007, it was meeting these global benchmarks.

Short-course chemotherapy: a treatment revolution 🔗

One of RNTCP’s most significant contributions was standardizing short-course chemotherapy. The treatment regimen typically consists of an intensive phase of two months with four drugs (Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol) followed by a continuation phase of four months with three drugs. This six-month regimen replaced longer, inconsistent treatment protocols that often led to poor compliance and drug resistance.

The introduction of Fixed Dose Combinations (FDCs) in 2016 further simplified treatment by combining multiple drugs into single tablets, administered according to weight bands. This approach reduced the pill burden for patients and improved treatment adherence.

Integration with primary healthcare 🔗

A crucial factor in the programme’s success has been its integration with India’s primary healthcare system. Rather than operating as a standalone vertical programme, TB services were woven into the broader National Health Mission infrastructure. This integration meant that existing health workers, facilities, and supply chains could be leveraged for TB control activities.

The programme operates through a four-tier hierarchy: the Central TB Division at the national level, State TB Cells, District TB Offices, and sub-district Tuberculosis Units. This structure ensures coordination from policy-making down to community-level implementation. Health and Wellness Centres now play an active role in TB screening, diagnosis referral, and treatment support.

Community engagement and NGO involvement 🔗

Recognizing that government efforts alone cannot eliminate TB, the programme has actively engaged civil society organizations. Interface NGOs have been designated to work closely with RNTCP, bridging gaps between communities and public health services. These organizations implement social mobilization activities, conduct awareness campaigns, and support patient adherence.

Non-governmental organizations contribute in multiple ways: public education through mass media, community mobilization for greater participation, engaging private healthcare providers, coordinating TB/HIV activities, and advocating for increased political commitment. The Tuberculosis Association of India, one of the oldest voluntary organizations in this space, has been serving the cause since 1939.

The Pradhan Mantri TB Mukt Bharat Abhiyaan, launched in 2022, exemplifies this community-focused approach. This initiative encourages citizens from all backgrounds to participate in TB elimination as “Ni-kshay Mitras” (TB-free friends). Over 1.6 lakh community supporters have registered to provide additional assistance to TB patients during their treatment journey.

Addressing drug-resistant tuberculosis 🔗

As the programme evolved, it had to confront the growing challenge of drug-resistant TB. In 2007, the Programmatic Management of Drug Resistant TB (PMDT) was introduced, achieving full geographical coverage by 2013.

Modern diagnostic capabilities have expanded dramatically. The network now includes laboratories certified for First-Line and Second-Line Drug Susceptibility Testing. Rapid molecular diagnostic tools like Cartridge Based Nucleic Acid Amplification Test (CB-NAAT/GeneXpert) and TrueNat systems can detect both TB and rifampicin resistance within hours, enabling faster initiation of appropriate treatment.

From control to elimination: NTEP vision 2025 🔗

In January 2020, RNTCP was renamed the National Tuberculosis Elimination Programme to reflect India’s ambitious goal of eliminating TB by 2025-five years ahead of global Sustainable Development Goal targets. This shift from “control” to “elimination” represents more than a name change; it signals intensified efforts across four strategic pillars: Detect, Treat, Prevent, and Build.

The programme has introduced several patient-centric initiatives. The Nikshay Poshan Yojana provides nutritional support of Rs. 500 monthly through direct benefit transfer to all notified TB patients. The Ni-kshay digital platform enables real-time case notification and tracking. In 2012, TB was made a notifiable disease, requiring all healthcare providers-public and private-to report cases.

Current challenges and the road ahead 🔗

Despite remarkable progress, significant challenges remain. India accounts for approximately 27% of global TB incidence, with an estimated 2.82 million new cases in 2022. The private healthcare sector, which manages over half of TB patients, still presents coordination challenges. Drug-resistant strains continue to emerge, and risk factors like HIV co-infection, diabetes, malnutrition, and tobacco use complicate prevention and treatment efforts.

Active case finding campaigns now screen millions of people annually in hard-to-reach areas using mobile TB diagnostic vans. Contact tracing identifies and treats latent infections before they become active disease. The public-private mix approach brings quality-assured services to patients wherever they seek care.

The evolution from NTCP to NTEP demonstrates India’s capacity to learn from experience, adopt international best practices, and adapt strategies to local contexts. While the 2025 elimination target remains ambitious, the foundations laid over six decades provide a robust platform for intensified action.

What do you think? How can communities better support TB patients in completing their treatment, and what role should private healthcare providers play in achieving TB elimination goals?

References

1. https://dghs.mohfw.gov.in/national-tuberculosis-elimination-programme.php
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC9672688/
3. https://www.nhp.gov.in/revised-national-tuberculosis-control-programme_pg
4. https://pubmed.ncbi.nlm.nih.gov/9141875/
5. https://en.wikipedia.org/wiki/Directly_observed_treatment,_short-course
6. https://journals.lww.com/mjdy/fulltext/2014/07010/revised_national_tuberculosis_control_program_.2.aspx
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC7550054/
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC3141449/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC1397734/
10. https://tbassnindia.org/